Hardcastle J, Hardcastle P T, Goldhill J
Department of Biomedical Science, The University, Sheffield, UK.
J Pharm Pharmacol. 1990 May;42(5):364-6. doi: 10.1111/j.2042-7158.1990.tb05431.x.
The effects of loperamide and loperamide oxide on basal and prostaglandin E2-stimulated fluid transport by rat small intestine have been investigated. In contrast to loperamide, loperamide oxide, when applied intraperitoneally, failed to inhibit either basal or prostaglandin E2-stimulated fluid transport. However, intraperitoneal administration of loperamide oxide following its incubation with the contents of the intestinal lumen under aerobic conditions resulted in an effective inhibition of fluid secretion. The activating material was present in the essentially non-particulate 3000 g supernatant fraction of the luminal contents and was heat-stable.
已对洛哌丁胺和氧化洛哌丁胺对大鼠小肠基础和前列腺素E2刺激的液体转运的影响进行了研究。与洛哌丁胺不同,氧化洛哌丁胺腹腔给药时,未能抑制基础或前列腺素E2刺激的液体转运。然而,在有氧条件下将氧化洛哌丁胺与肠腔内容物孵育后腹腔给药,可有效抑制液体分泌。活性物质存在于肠腔内容物基本无颗粒的3000g上清液部分,且耐热。